308 related articles for article (PubMed ID: 17591895)
21. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.
Gérain J; Liénard D; Pampallona S; Baumgartner M; Rüegg C; Buurman WA; Eggermont A; Lejeune F
Cytokine; 1997 Dec; 9(12):1034-42. PubMed ID: 9417816
[TBL] [Abstract][Full Text] [Related]
22. Circulating soluble tumour necrosis factor receptors in patients with epidermodysplasia verruciformis as compared to patients with cutaneous tumours in the general population.
Malejczyk M; Józwiak J; Jablonska S; Pfister H; Majewski S; Malejczyk J
Oncol Rep; 2005 Jan; 13(1):151-5. PubMed ID: 15583817
[TBL] [Abstract][Full Text] [Related]
23. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum levels of TNF-alpha, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation.
Haseeb MA; Shirazian DJ; Preis J
Cytokine; 2001 Sep; 15(5):266-9. PubMed ID: 11594791
[TBL] [Abstract][Full Text] [Related]
25. Macrophage migration inhibitory factor in ocular fluids of patients with uveitis.
Taguchi C; Sugita S; Tagawa Y; Nishihira J; Mochizuki M
Br J Ophthalmol; 2001 Nov; 85(11):1367-71. PubMed ID: 11673308
[TBL] [Abstract][Full Text] [Related]
26. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
Su TR; Chang KL; Lee CH; Chen CH; Yang YH; Shieh TY
Oral Oncol; 2004 Sep; 40(8):804-10. PubMed ID: 15288835
[TBL] [Abstract][Full Text] [Related]
27. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies.
Perez VL; Papaliodis GN; Chu D; Anzaar F; Christen W; Foster CS
Ocul Immunol Inflamm; 2004 Sep; 12(3):193-201. PubMed ID: 15385196
[TBL] [Abstract][Full Text] [Related]
29. Soluble Fas ligand expression in the ocular fluids of uveitis patients.
Sotozono C; Sano Y; Suzuki T; Tada R; Ikeda T; Nagata S; Kinoshita S
Curr Eye Res; 2000 Jan; 20(1):54-7. PubMed ID: 10611715
[TBL] [Abstract][Full Text] [Related]
30. Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthrotic patients.
Bellometti S; Galzigna L; Richelmi P; Gregotti C; Bertè F
Int J Tissue React; 2002; 24(2):57-64. PubMed ID: 12182234
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of soluble tumor necrosis factor receptor in patients with active tuberculosis].
Onohara Y; Tomoda K; Nakaya M; Yoshikawa M; Tsukaguchi K; Tokuyama T; Hu A; Hukuoka K; Yamamoto C; Yoneda T; Narita N
Kekkaku; 1996 Jul; 71(7):435-8. PubMed ID: 8776958
[TBL] [Abstract][Full Text] [Related]
32. Capacity of ocular infiltrating T helper type 1 cells of patients with non-infectious uveitis to produce chemokines.
Takase H; Sugita S; Taguchi C; Imai Y; Mochizuki M
Br J Ophthalmol; 2006 Jun; 90(6):765-8. PubMed ID: 16464967
[TBL] [Abstract][Full Text] [Related]
33. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
Tesarová P; Kvasnicka J; Umlaufová A; Homolková J; Jirsa M; Tesar V
Cas Lek Cesk; 1998 May; 137(11):341-5. PubMed ID: 9727208
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
[TBL] [Abstract][Full Text] [Related]
35. [Changes in concentrations of tumor necrosis factor TNF and its soluble receptors type 1 (sTNF-r1) and type 2 (sTNF-R2) in serum of patients with ST-segment elevation myocardial infarction].
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Smycz M
Wiad Lek; 2011; 64(2):71-4. PubMed ID: 22026268
[TBL] [Abstract][Full Text] [Related]
36. Stabilisation of functional tumor necrosis factor-alpha by its soluble TNF receptors.
De Groote D; Grau GE; Dehart I; Franchimont P
Eur Cytokine Netw; 1993; 4(5):359-62. PubMed ID: 8117937
[TBL] [Abstract][Full Text] [Related]
37. [Serum levels of soluble receptors for tumor necrosis factor in sarcoidosis].
Kawaguchi H; Ina Y; Sato S; Ito S; Sugiura Y; Hasegawa Y; Takada K; Yamamoto M; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):850-5. PubMed ID: 7474565
[TBL] [Abstract][Full Text] [Related]
38. Chronological changes in circulating levels of soluble tumor necrosis factor receptors 1 and 2 in rats with carbon tetrachloride-induced liver injury.
Ijiri Y; Kato R; Sadamatsu M; Takano M; Okada Y; Tanaka K; Hayashi T
Toxicology; 2014 Feb; 316():55-60. PubMed ID: 24389507
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha concentrations in the aqueous humor of patients with glaucoma.
Sawada H; Fukuchi T; Tanaka T; Abe H
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):903-6. PubMed ID: 19737888
[TBL] [Abstract][Full Text] [Related]
40. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
Zhang J; Tao LJ; Ning JP; Xu H; Ai YH; Zhao SP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):81-4. PubMed ID: 14764220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
